AAAAAA
Results:
1-17
|
Results: 17
Authors:
KURBACHER CM
CREE IA
BRUCKNER HW
BRENNE U
KURBACHER JA
MULLER K
ACKERMANN T
GILSTER TJ
WILHELM LM
ENGEL H
MALLMANN PK
ANDREOTTI PE
Citation: Cm. Kurbacher et al., USE OF AN EX-VIVO ATP LUMINESCENCE ASSAY TO DIRECT CHEMOTHERAPY FOR RECURRENT OVARIAN-CANCER, Anti-cancer drugs, 9(1), 1998, pp. 51-57
Authors:
KURBACHER CM
BRUCKNER HW
CREE IA
KURBACHER JA
WILHELM L
POCH G
INDEFREI D
MALLMANN P
ANDREOTTI PE
Citation: Cm. Kurbacher et al., MITOXANTRONE COMBINED WITH PACLITAXEL AS SALVAGE THERAPY FOR PLATINUM-REFRACTORY OVARIAN-CANCER - LABORATORY STUDY AND CLINICAL PILOT TRIAL, Clinical cancer research, 3(9), 1997, pp. 1527-1533
Authors:
KURBACHER CM
MUNSCH S
BRENNE U
GILSTER T
MALLMANN P
BRUCKNER HW
Citation: Cm. Kurbacher et al., DOSE-RESPONSE IN PRIMARY OVARIAN-CANCER EVALUATED BY AN EX-VIVO ATP CHEMOSENSITIVITY ASSAY, European journal of cancer, 33, 1997, pp. 539-539
Authors:
KAMTHAN AG
MORRIS JC
DALTON J
MANDELI JP
CHESSER MR
LEBEN D
COOPERMAN A
BRUCKNER HW
Citation: Ag. Kamthan et al., COMBINED-MODALITY THERAPY FOR STAGE-II AND STAGE-III PANCREATIC-CARCINOMA, Journal of clinical oncology, 15(8), 1997, pp. 2920-2927
Authors:
CREE IA
KURBACHER CM
UNTCH M
SUTHERLAND LA
HUNTER EM
SUBEDI AMC
JAMES EA
DEWAR JA
PREECE PE
ANDREOTTI PE
BRUCKNER HW
Citation: Ia. Cree et al., CORRELATION OF THE CLINICAL-RESPONSE TO CHEMOTHERAPY IN BREAST-CANCERWITH EX-VIVO CHEMOSENSITIVITY, Anti-cancer drugs, 7(6), 1996, pp. 630-635
Authors:
KURBACHER CM
WAGNER U
KOLSTER B
ANDREOTTI PE
KREBS D
BRUCKNER HW
Citation: Cm. Kurbacher et al., ASCORBIC-ACID (VITAMIN-C) IMPROVES THE ANTINEOPLASTIC ACTIVITY OF DOXORUBICIN, CISPLATIN, AND PACLITAXEL IN HUMAN BREAST-CARCINOMA CELLS IN-VITRO, Cancer letters, 103(2), 1996, pp. 183-189
Authors:
KURBACHER CM
CREE IA
BRENNE U
BRUCKNER HW
KURBACHER JA
MALLMANN P
ANDREOTTI PE
KREBS D
Citation: Cm. Kurbacher et al., HETEROGENEITY OF IN-VITRO CHEMOSENSITIVITY IN PERIOPERATIVE BREAST-CANCER CELLS TO MITOXANTRONE VERSUS DOXORUBICIN EVALUATED BY A MICROPLATE ATP BIOLUMINESCENCE ASSAY, Breast cancer research and treatment, 41(2), 1996, pp. 161-170
Authors:
GATTANI AM
MANDELI J
BRUCKNER HW
Citation: Am. Gattani et al., TUMOR-MARKERS IN PATIENTS WITH PANCREATIC-CARCINOMA, Cancer, 78(1), 1996, pp. 57-62
Authors:
KURBACHER CM
BRUCKNER HW
ANDREOTTI PE
KURBACHER JA
SASS G
KREBS D
Citation: Cm. Kurbacher et al., IN-VITRO ACTIVITY OF TITANOCENEDICHLORIDE VERSUS CISPLATIN IN 4 OVARIAN-CARCINOMA CELL-LINES EVALUATED BY A MICROTITER PLATE ATP BIOLUMINESCENCE ASSAY, Anti-cancer drugs, 6(5), 1995, pp. 697-704
Authors:
KALECHMAN Y
SHANI A
DOVRAT S
ALBECK M
BRUCKNER HW
SREDNI B
Citation: Y. Kalechman et al., SYNERGISTIC ANTITUMOR EFFECT OF THE IMMUNOMODULATOR ASIOI AND TAXOL IN EXPERIMENTAL MURINE MODEL, Experimental hematology, 23(8), 1995, pp. 799-799
Authors:
LEE JM
BRUCKNER HW
SZRAJER L
BRENNE U
SCHINDELHEIM G
ANDREOTTI PE
Citation: Jm. Lee et al., TAXOL INHIBITS GROWTH OF MESOTHELIOMA XENOGRAFTS, Anticancer research, 15(3), 1995, pp. 693-696
Authors:
ANDREOTTI PE
CREE IA
KURBACHER CM
HARTMANN DM
LINDER D
HAREL G
GLEIBERMAN I
CARUSO PA
RICKS SH
UNTCH M
SARTORI C
BRUCKNER HW
Citation: Pe. Andreotti et al., CHEMOSENSITIVITY TESTING OF HUMAN TUMORS USING A MICROPLATE ADENOSINE-TRIPHOSPHATE LUMINESCENCE ASSAY - CLINICAL CORRELATION FOR CISPLATIN RESISTANCE OF OVARIAN-CARCINOMA, Cancer research, 55(22), 1995, pp. 5276-5282
Authors:
ANDREOTTI PE
LINDER D
HARTMANN DM
CREE IA
PAZZAGLI M
BRUCKNER HW
Citation: Pe. Andreotti et al., TCA-100 TUMOR CHEMOSENSITIVITY ASSAY - DIFFERENCES IN SENSITIVITY BETWEEN CULTURED TUMOR-CELL LINES AND CLINICAL-STUDIES, Journal of bioluminescence and chemiluminescence, 9(6), 1994, pp. 373-378
Authors:
BRUCKNER HW
KALNICKI S
DALTON J
SCHWARTZ GK
CHESSER MR
MANDELI J
JANUS C
Citation: Hw. Bruckner et al., COMBINED MODALITY THERAPY INCREASING LOCAL-CONTROL OF PANCREATIC-CANCER, Cancer investigation, 11(3), 1993, pp. 241-246
Authors:
BRUCKNER HW
CHESSER MR
MANDELI J
FARBER LA
DIGIOVANNI G
Citation: Hw. Bruckner et al., CIRCULATING PANCREATIC-POLYPEPTIDE IN PATIENTS WITH ADENOCARCINOMA OFTHE BILE-DUCT, Acta oncologica, 32(6), 1993, pp. 627-629
Authors:
LEE JM
ERLICH RB
BRUCKNER HW
SZRAJER L
OHNUMA T
Citation: Jm. Lee et al., A SOMATOSTATIN ANALOG (SMS 201-995) ALTERS THE TOXICITY OF 5-FLUOROURACIL IN SWISS MICE, Anticancer research, 13(5A), 1993, pp. 1453-1456
Authors:
WOOLLEY PV
NAUTA R
SMITH FP
LINDBLAD AS
PETRELLI N
HERRERA L
DOUGLASS HO
MAYER RJ
BRUCKNER HW
DALTON J
BONADONNA G
GENNARI L
HALL TC
WEAVER DW
LEICHMAN L
KALSER MH
BENEDETTO P
MUGGIA FM
GREEN M
GREENWALD E
LEVIN B
GAYNOR E
HARRIS J
MARSH JC
BARWICK K
KNOWLTON AH
LIVSTONE EM
BUKOWSKI RM
LOUTFI A
RAMIREZ G
THOMAS PRM
Citation: Pv. Woolley et al., RADIATION-THERAPY AND FLUOROURACIL WITH OR WITHOUT SEMUSTINE FOR THE TREATMENT OF PATIENTS WITH SURGICAL ADJUVANT ADENOCARCINOMA OF THE RECTUM, Journal of clinical oncology, 10(4), 1992, pp. 549-557
Risultati:
1-17
|